Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...

By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

Is the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience.

One current research avenue is to look at currently-approved medications that are used for other diseases, an approach that is called drug repurposing. A new study has identified two cancer ...

Origami is collaborating with Ipsen to develop molecules designed to remove or correct abnormal proteins in neurodegenerative diseases.

This new article publication from Acta Pharmaceutica Sinica B, discusses how neg-entropy is the true drug target for chronic diseases.

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...